-- Preview Email Newsletter
*Maryland Editor Tipoffs Newsletter for 2025-08-23 ( 7 items ) |
Alsobrooks Statement on Kilmar Abrego Garcia (10)
WASHINGTON, Aug. 22 -- Sen. Angela Alsobrooks, D-Maryland, issued the following news release:
* * *
Original text here:
* * *
Alsobrooks Statement on Kilmar Abrego Garcia
*
August 22, 2025
WASHINGTON, DC - Senator Angela Alsobrooks (D-Md.) released the following statement after news that Kilmar Abrego Garcia was released from custody:
"We are a nation of laws, and this President would do well to remember that.
"Kilmar Abrego Garcia will finally be afforded due process despite this Ad more PR
Congressman Ivey Joins Maryland Congressional Delegation In Bipartisan Push to Urge Administration to Reverse Denial of Federal Disaster Assistance (10)
WASHINGTON, Aug. 22 -- Rep. Glenn Ivey, D-Maryland, issued the following news release:
* * *
Congressman Ivey Joins Maryland Congressional Delegation In Bipartisan Push to Urge Administration to Reverse Denial of Federal Disaster Assistance
*
WASHINGTON - Congressman Glenn Ivey joined U.S. Senators Chris Van Hollen and Angela Alsobrooks and U.S. Representatives April McClain Delaney, Steny Hoyer, Andy Harris, Kweisi Mfume, Jamie Raskin, Sarah Elfreth, and Johnny Olszewski (all Md.) wrote to more PR
In Bipartisan Push, Maryland Congressional Delegation Urges Administration to Reverse Denial of Federal Disaster Assistance (10)
WASHINGTON, Aug. 22 -- Rep. April McClain Delaney, D-Maryland, issued the following news release:
* * *
In Bipartisan Push, Maryland Congressional Delegation Urges Administration to Reverse Denial of Federal Disaster Assistance
*
August 21, 2025
WASHINGTON - Today, U.S. Senators Chris Van Hollen and Angela Alsobrooks and U.S. Representatives April McClain Delaney, Steny Hoyer, Andy Harris, Kweisi Mfume, Jamie Raskin, Glenn Ivey, Sarah Elfreth, and Johnny Olszewski (all Md.) wrote to Presid more PR
Judiciary Democrats and E&C Launch Investigation Into Skydance-Paramount Merger (10)
WASHINGTON, Aug. 22 -- Rep. Jamie Raskin, D-Maryland, ranking member of the of the House Judiciary Committee, issued the following news release:
* * *
Judiciary Democrats and E&C Launch Investigation into Skydance-Paramount Merger
Top House Democrats Seek Answers on Whether the Terms of the Government-Approved Merger Includes Censorship of Editorial Products at the Network, Details on the Millions in Free Trump Advertising, and More
*
Judiciary Committee Ranking Member Jamie Raskin (D-MD) a more PR
NRC Rejects Petition on Palisades Nuclear Plant Funds (10)
WASHINGTON, Aug. 21 (TNSFR) -- The Nuclear Regulatory Commission has denied a petition from several groups who alleged that the owners of the Palisades Nuclear Plant misused decommissioning funds. The groups, which includes Beyond Nuclear, Takoma Park, Maryland, Michigan Safe Energy Future and Don't Waste Michigan, claimed that Holtec Palisades LLC and Holtec Decommissioning International LLC, both located in Camden, New Jersey, spent money from the decommissioning trust fund on activities relat more PR
Secretary Noem Condemns the Release of Kilmar Abrego Garcia, a MS-13 Gang Member, Human Trafficker, Wife Beater, and Child Predator (10)
WASHINGTON, Aug. 22 -- The U.S. Department of Homeland Security issued the following news release:
* * *
Secretary Noem Condemns the Release of Kilmar Abrego Garcia, a MS-13 Gang Member, Human Trafficker, Wife Beater, and Child Predator
*
An unhinged judge in Maryland ordered his release, despite his status as an MS-13 gang member, being indicted by a grand jury for human trafficking, and being subject to arrest under immigration law
WASHINGTON - Today, U.S District Court Judge Paula Xinis more PR
Vici Health Sciences Seeks DEA Import Registration for Fentanyl-Related Compounds (10)
WASHINGTON, Aug. 22 (TNSFR) -- The U.S. Department of Justice Drug Enforcement Administration has published a notice regarding an application from Vici Health Sciences LLC, Elkridge, Maryland, for authorization to import fentanyl-related compounds. This controlled substance is a Schedule I drug, and the company plans to use it in a manufacturing process to support its research and clinical trials.
The application, submitted on May 30, 2025, specifies that the company's activity is limited to th more PR
|